Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bioxyne Limited ( (AU:BXN) ) has shared an announcement.
Bioxyne Limited announced a change in the director’s interest, with Mr. Anthony Ho disposing of 1,500,000 ordinary shares valued at $43,500 through an on-market sale and reallocation between accounts. This change reflects a strategic adjustment in the director’s holdings, potentially impacting investor perceptions and market dynamics for Bioxyne’s securities.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry, focusing on the development and commercialization of health and wellness products. The company is known for its probiotic and immune health products, targeting both consumer and clinical markets.
Average Trading Volume: 3,873,822
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$86.59M
For detailed information about BXN stock, go to TipRanks’ Stock Analysis page.